Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

3.3%

1 terminated out of 30 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

20%

6 trials in Phase 3/4

Results Transparency

45%

5 of 11 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (6)
Early P 1 (1)
P 1 (2)
P 2 (5)
P 3 (4)
P 4 (2)

Trial Status

Completed11
Not Yet Recruiting11
Recruiting6
Terminated1
Active Not Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07725575Phase 4CompletedPrimary

Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia

NCT07417111Not ApplicableRecruitingPrimary

Continued Pressure for Alveolar Protection (CPAP Trial)

NCT07101640Phase 1RecruitingPrimary

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

NCT07109791Not Yet Recruiting

National Surveillance and Prevention of Neonatal VAP

NCT07652684Phase 4RecruitingPrimary

Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

NCT07577180Phase 3CompletedPrimary

Oral Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia in Preterm Infants

NCT04545866Phase 3Active Not RecruitingPrimary

The Budesonide in Babies (BiB) Trial

NCT07502781Not ApplicableNot Yet Recruiting

Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants

NCT07487259Not Yet RecruitingPrimary

Impact of the Early Life Virome Development on Bronchopulmonary Dysplasia in Preterm Neonates

NCT07447739Phase 2Not Yet Recruiting

Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively?

NCT07273643Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

NCT07377955Not ApplicableNot Yet Recruiting

Combined Oscillation-Volume guarantEe Study

NCT07120971Early Phase 1RecruitingPrimary

Metformin for Premature Infants With Bronchopulmonary Dysplasia

NCT07052201Phase 3Not Yet Recruiting

Dexamethasone Regimens for BPD Prevention in Preterm Infants

NCT07134387RecruitingPrimary

Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

NCT01702805Not ApplicableCompleted

Transfusion of Prematures Trial

NCT07123948Not Yet Recruiting

The Correlation Between Red Cell Transfusion and Complications of Prematurity

NCT07058025Phase 2Not Yet RecruitingPrimary

Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

NCT06940856Not Yet RecruitingPrimary

Chloride Imbalance in Preterm Infants

NCT02907593Phase 1TerminatedPrimary

Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial

Scroll to load more

Research Network

Activity Timeline